Ident. | Authors (with country if any) | Title |
---|
001135 (2013) |
Prabha Ranganathan [États-Unis] | Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors |
001137 (2013) |
Claudia Ravaglia [Italie] ; Carlo Gurioli [Italie] ; Gian Luca Casoni [Italie] ; Silvia Asioli [Italie] ; Venerino Poletti [Italie] | Fever, splenomegaly and lymphopenia in sarcoidosis |
001146 (2013) |
Inbal Braunstein [États-Unis] ; Victoria Werth [États-Unis] | Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy |
001188 (2013) |
Fariz Yahya [Malaisie] ; Raja Jasmin [Malaisie] ; Chin Teck Ng [Malaisie] ; Tien Eang Cheah [Malaisie] ; Sargunan Sockalingam [Malaisie] | Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement |
001244 (2013) |
Duygu Emine Ersozlu Bozkirli [Turquie] ; Ilknur Kozanoglu [Turquie] ; Emre Bozkirli [Turquie] ; Eftal Yucel [Turquie] | Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis |
001326 (2012) |
H. Ahmadzai ; M. C. Kiernan ; D. Wakefield [Australie] ; P. S. Thomas | Treatment of refractory neurosarcoidosis with TNF‐inhibitors: what lies ahead? |
001379 (2012) |
Christina Lam [États-Unis, Canada] ; Ruth Ann Vleugels [États-Unis] | Management of cutaneous dermatomyositis |
001400 (2012) |
J. S. Wee [Royaume-Uni] ; P. J. Shirlaw [Royaume-Uni] ; S. J. Challacombe [Royaume-Uni] ; J. F. Setterfield [Royaume-Uni] | Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients |
001406 (2012) |
Fiona L. Dignan [Royaume-Uni] ; Persis Amrolia [Royaume-Uni] ; Andrew Clark [Royaume-Uni] ; Jacqueline Cornish [Royaume-Uni] ; Graham Jackson [Royaume-Uni] ; Prem Mahendra [Royaume-Uni] ; Julia J. Scarisbrick [Royaume-Uni] ; Peter C. Taylor [Royaume-Uni] ; Bronwen E. Shaw [Royaume-Uni] ; Michael N. Potter [Royaume-Uni] | Diagnosis and management of chronic graft‐versus‐host disease |
001409 (2012) |
Christopher B. Hansen [États-Unis] ; Kevin W. Dahle [États-Unis] | Cutaneous lupus erythematosus |
001569 (2011) |
Yiyun Yu [États-Unis, République populaire de Chine] ; Antonio La Cava [États-Unis] | Current drugs in systemic lupus erythematosus |
001739 (2010) |
| Case Report |
001753 (2010) |
| 2.7. Systemic lupus erythematosus, Sjögren's and antiphospholipid syndrome ‐ clinical aspects, comorbidities and complications |
001810 (2009) |
Catherine A. Heyneman [États-Unis] | Systemic Lupus Erythematosus: A Therapeutic Update |
001818 (2009) |
F. Goldblatt [Royaume-Uni] ; S. Chambers [Royaume-Uni] ; A. Rahman [Royaume-Uni] ; Da Isenberg [Royaume-Uni] | Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality |
001959 (2008) |
S. Bernatsky [Canada] ; L. Joseph [Canada] ; J-F Boivin [Canada] ; C. Gordon [Canada] ; M. Urowitz [États-Unis] ; D. Gladman [États-Unis] ; P R Fortin [États-Unis] ; E. Ginzler [Corée du Sud] ; S-C Bae [Canada] ; S. Barr [Royaume-Uni] ; S. Edworthy [Royaume-Uni] ; D. Isenberg [États-Unis] ; A. Rahman [États-Unis] ; M. Petri [États-Unis] ; G S Alarc N [États-Unis] ; C. Aranow [États-Unis] ; M-A Dooley [Canada] ; R. Rajan [Canada] ; J-L Sénécal [Canada] ; M. Zummer [États-Unis] ; S. Manzi [États-Unis] ; R. Ramsey-Goldman [Canada, Royaume-Uni, États-Unis, Corée du Sud] ; A E Clarke [Canada] | The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study |
001968 (2008) |
Robert Kim [États-Unis] ; Keith C. Meyer | Review: Therapies for interstitial lung disease: past, present and future |
001A08 (2008) |
A. Delluc [France] ; N. Limal [France] ; X. Puéchal [France] ; C. Francès [France] ; J C Piette [France] ; P. Cacoub [France] | Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome |
001A09 (2008) |
G. Bertsias [Grèce] ; J P A. Ioannidis [Grèce] ; J. Boletis [Grèce] ; S. Bombardieri [Italie] ; R. Cervera [Espagne] ; C. Dostal [République tchèque] ; J. Font [Espagne] ; I M Gilboe [Norvège] ; F. Houssiau [Belgique] ; T. Huizinga [Pays-Bas] ; D. Isenberg [Royaume-Uni] ; C G M. Kallenberg [Pays-Bas] ; M. Khamashta [Royaume-Uni] ; J C Piette [France] ; M. Schneider [Allemagne] ; J. Smolen [Autriche] ; G. Sturfelt [Suède] ; A. Tincani [Italie] ; R. Van Vollenhoven [Suède] ; C. Gordon [Royaume-Uni] ; D T Boumpas [Grèce] | EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics |
001B71 (2007) |
Lester E. Mertz [États-Unis] ; Janis E. Blair [États-Unis] | Coccidioidomycosis in Rheumatology Patients |
001B84 (2007) |
G. Ruiz-Irastorza [Espagne] ; A. Ugarte [Espagne] ; M V Egurbide [Espagne] ; M. Garmendia [Espagne] ; J I Pijoan [Espagne] ; A. Martinez-Berriotxoa [Espagne] ; C. Aguirre [Espagne] | Antimalarials may influence the risk of malignancy in systemic lupus erythematosus |
001B89 (2007) |
S. Chaiamnuay [États-Unis] ; L W Heck [États-Unis] ; W C Bell [États-Unis] ; H M Bastian [États-Unis] | Acute granulomatous lupus pneumonitis: the first case report |
001C44 (2006) |
B. Y. H. Thong ; S. Vasoo [Singapour] ; E. T. Koh | The use of anti‐tumour necrosis factor‐α therapies for rheumatoid arthritis in Singapore |
001C62 (2006) |
A. Holvast [Pays-Bas] ; A. Huckriede [Pays-Bas] ; J. Wilschut [Pays-Bas] ; G. Horst [Pays-Bas] ; J J C. De Vries [Pays-Bas] ; C A Benne [Pays-Bas] ; C G M. Kallenberg [Pays-Bas] ; M. Bijl [Pays-Bas] | Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease |
001C81 (2006) |
James P. Russell [États-Unis] ; Lawrence E. Gibson [États-Unis] | Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment |
001E51 (2005) |
| Oral presentations |
001F33 (2004) |
J. Kanitakis [France] ; S. Euvrard [France] ; A. C. Butnaru [France] ; A. Claudy [France] | Verruciform xanthoma of the scrotum in a renal transplant patient |
001F45 (2004) |
Kam Hon Yoon [Singapour] | Successful usage of tacrolimus (FK506) in resistant/relapsed rheumatic diseases |
001F51 (2004) |
Y. Amo [Japon] ; M. Masuzawa [Japon] ; Y. Hamada [Japon] ; K. Katsuoka [Japon] | Serum concentrations of vascular endothelial growth factor‐D in angiosarcoma patients |
001F53 (2004) |
G. Dawn [Niger] ; S. C. Holmes [Niger] | Scleromyxoedema‐like eruption following haemodialysis or nephrogenic fibrosing dermopathy? |
001F61 (2004) |
P. Fiallo [Italie] | Reduced therapeutic activity of warfarin during treatment with oral isotretinoin |
001F74 (2004) |
| News and Notices |
001F77 (2004) |
I. Hayashi [Japon] ; T. Harada [Japon] ; M. Muraoka [Japon] ; M. Ishii [Japon] | Malignant proliferating trichilemmal tumour and CAV (cisplatin, adriamycin, vindesine) treatment |
001F79 (2004) |
A. Di Carlo [Italie] | Lisinopril and Kaposi's sarcoma |
001F80 (2004) |
N. Bilen [Turquie] | Lisinopril and Kaposi's sarcoma: reply from authors |
001F82 (2004) |
S. Yashar [États-Unis] ; K. F. Han [États-Unis] ; J. C. Haley [États-Unis] | Lichen sclerosus–lichen planus overlap in a patient with hepatitis C virus infection |
001F84 (2004) |
A. Macario-Barrel ; A. Zeghnoun ; P. Young ; L. Froment ; H. Levesque ; F. Caron [France] ; P. Musette ; P. Joly | Influence of environmental temperature on the occurrence of non‐necrotizing cellulitis of the leg |
001F92 (2004) |
Y-J. Deng [République populaire de Chine] ; F. Hao [République populaire de Chine] ; C-L. Zhou [République populaire de Chine] ; R-S. Sun [République populaire de Chine] ; M-M. Xiang [République populaire de Chine] ; J-W. Wang [République populaire de Chine] ; B-Y. Zhong [République populaire de Chine] ; Q-Y. Ye [République populaire de Chine] ; R-Q. Liu [République populaire de Chine] | Generalized eruptive histiocytosis: a possible therapeutic cure? |
001F95 (2004) |
G. Herrmann [Allemagne] ; L. Schneider [Allemagne] ; T. Krieg [Allemagne] ; N. Hunzelmann [Allemagne] ; K. Scharffetter-Kochanek [Allemagne] | Efficacy of danazol treatment in a patient with the new variant of hereditary angio‐oedema (HAE III) |
002002 (2004) |
Neil H. Cox | Dermatology – just the facts |
002003 (2004) |
M. E. Kirkup ; E. A. Sheffield ; L. J. Sacks ; J. E. Sansom | Delayed onset of bullous reaction with severe deep skin necrosis in association with sertraline |
002007 (2004) |
M. T. Gupta ; H. R. Jerajani | Control of childhood pemphigus erythematosus with steroids and azathioprine |
002011 (2004) |
| British Society for Dermatopathology: Summaries of Papers |
002022 (2004) |
C. Réuena ; L. Requena ; S. Blanco ; C. Álvarez ; C. Galache ; E. Rodríguez | Acral ulcerations and osteolysis, a severe form of the carpal tunnel syndrome |
002028 (2004) |
K. Tomizawa ; S. Tanaka ; B. Saito ; K. Ota [Japon] | A peculiar type of dystrophic calcinosis cutis affecting the surface of damaged genital skin and mucosa in an elderly woman with a vesicovaginal fistula |
002029 (2004) |
P. Rubegni [Italie] ; P. Sbano [Italie] ; M. Risulo [Italie] ; S. Poggiali [Italie] ; M. Fimiani [Italie] | A case of reticular erythematous mucinosis treated with topical tacrolimus |
002030 (2004) |
T. Petrella [États-Unis] ; M. A. Teitell [États-Unis] ; C. Spiekermann ; C. J. L. M. Meijer [Pays-Bas] ; F. Franck [France] ; I. Enache [France] | A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm) |
002120 (2003) |
R. Malik [Australie] ; P. Zunino ; Gb Hunt | Complete heart block associated with lupus in a dog |
002202 (2002) |
Navaz Hiramanek ; Steven Kossard [Australie] ; Ross Stc Barnetson | Multicentric reticulohistiocytosis presenting with a rash and arthralgia |
002231 (2002) |
Jack B. Cohen [États-Unis] | Cutaneous involvement of dermatomyositis can respond to Dapsone therapy |
002240 (2002) |
E N Harris [États-Unis] | Antirheumatic drugs in pregnancy |